
Qosina
Qosina, a global supplier of OEM single-use components to the medical and pharmaceutical industries, announced a partnership with ILC Dover, a leader in the innovative design and production of solutions for biopharmaceutical, pharmaceutical and medical device markets.
ILC Dover has partnered with Qosina to ensure assurance of supply of their single-use bioprocess systems by leveraging Qosina’s extensive selection and inventory of bioprocess components, focus on business continuity, consistent quality, change control and corporate social responsibility. ILC Dover has secured its component supply to rapidly respond to customer demand and aggressive timelines by outsourcing their supply chain operations to Qosina.
In conjunction with this new partnership, Qosina has expanded its product portfolio to include liquid single-use chamber bags from ILC Dover. These high-performance fluid storage and transfer chambers with optimized reliability, throughput and quality assurance for upstream and downstream bioprocessing applications are the perfect addition to the Qosina line.
The liquid bag chambers feature a TruFLO port design, which facilitates optimized edge-seal integrity and superior flow rates. The low-profile design coupled with the internal funnel shape maximizes product recovery. All liquid single-use chambers are manufactured with industry-proven, medical-grade Renolit 9101 film, a multilayer film composed of a high-purity biocompatible polyethylene (PE) contact layer with internal ethylene vinyl alcohol (EVOH) oxygen barrier and an extremely low extractables and leachables profile. This film provides superior clarity, flexibility, and strength, offers resistance to a wide range of chemicals, and is stable in a temperature range of -45°C to 60°C.
Available configurations range from 50ml to 50L in a 2- or 3-port design. Improved handling designs include a robust hanging grommet for smaller sizes (50ml to 1L) and reinforced, ergonomic handles for larger sizes (2L to 50L).
Qosina is a one-stop source for single-use bioprocess components, with low minimum order quantities, a liberal sampling policy and bill of material kitting, all supported by regulatory documentation and backed by Qosina’s assurance of supply.
Get curated news on YOUR industry.
Enter your email to receive our newsletters.Latest from Today's Medical Developments
- CERATIZIT achieves SBTi validation for emissions goals
- Applied Motion Products’ MLA & MEA series linear actuators
- Arterex expands portfolio with Xponent Global acquisition
- Meet the Digimar 814 C: precision and efficiency in metrology
- Blum-Novotest opens new Competence Center in Erlanger, Kentucky
- HydroPlasma: The future of surface cleaning in high-tech industries
- Heule partners with Center for Machining Excellence
- Down the road: What really is next for electric vehicles?